Patent details

1149163 Title:

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
1149163
WO Application Number:
GB00000257
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Non-filing of the translation/ non-submission of payment (art. 52.4A Row1995)
Application number:
9012527
WO Publication Number:
WO00044772
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:
EP1149163;

Dates

Filing date:
31/01/2000
Grant date:
03/12/2008
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
03/12/2008
EP B1 Publication Date:
03/12/2008
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
30/01/2020
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
03/12/2008

Applicant/holder

From:
03/12/2008
 
 

 

Name:
Novozymes Biopharma UK Limited
Address:
Nottingham NG7 1FD, United Kingdom (GB)

Inventor

1

Name:
VAN URK, Hendrik, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

2

Name:
MEAD, David John, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

3

Name:
MORTON, Philip Harvey, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

4

Name:
CARTWRIGHT, Andrew John, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

5

Name:
CAMERON, Jason, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

6

Name:
BALLANCE, David James, Aventis Behring
Address:
United States of America (US)

7

Name:
GRANDGEORGE, Michel G. J., Aventis Behring GmbH
Address:
Germany (DE)

8

Name:
BEREZENKO, Stephen, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

9

Name:
WOODROW, John Rodney, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

10

Name:
SLEEP, Darrell, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

11

Name:
VERON, Jean-Luc Bernard, Novozymes Biopharma UK Limited
Address:
United Kingdom (GB)

Priority

Priority Patent Number:
9902000
Priority Date:
30/01/1999
Priority Country:
United Kingdom (GB)

Classification

IPC or IDT classification:
C07K1/18; C07K1/22; C12N15/14; C12N15/81; C12P21/02;

Publication

Bulletin

1

Bulletin Heading:
VE1
Journal edition number:
200905
Publication date:
06/05/2009
Description:
Vervallen Europese octrooien wegens niet-indiening van een vertaling in het Nederlands of wegens niet-betaling van het verschuldigde recht

2

Bulletin Heading:
PE1
Journal edition number:
200902
Publication date:
02/02/2009
Description:
Verleende Europese octrooien in nummervolgorde

Terms/Procedural Changes

Description:
Termijn voor indienen vertaling Europees octrooi [EN]
Date:
03/03/2009

Correspondence

1

Sent On Date:
13/03/2009
Letter Type:
Vervalbrief [EN]
Reference:
To:
-

2

Sent On Date:
04/12/2008
Letter Type:
Termijnbrief [EN]
Reference:
BULLETIN 0849
To:
-

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
R.S. Bassett
Filing date Document type Document Description Number of pages File Type